De Graeve, Diana; Beutels, Philippe - In: PharmacoEconomics 22 (2004) 11, pp. 719-740
In this review, the economic aspects of pneumococcal pneumonia are analysed, including the costs, cost effectiveness … and cost benefit of treatment and prevention. We identified eight cost-of-illness studies, 15 analyses comparing the costs … drug costs and vague or disputable sources of cost information. In the US, hospitalisation costs resulting from CAP can be …